UB Paderborn / Katalog / Suche / in CDI

Interferon‐Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection

Hepatology (Baltimore, Md.), 2019-11, Vol.70 (5), p.1506-1520

2019

Link zum Volltext

Verfügbarkeit prüfen

Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a

Hepatology (Baltimore, Md.), 2014-11, Vol.60 (5), p.1551-1562

2014

Link zum Volltext

Verfügbarkeit prüfen

Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate

PLoS pathogens, 2012-04, Vol.8 (4), p.e1002653-e1002653

2012

Link zum Volltext

Verfügbarkeit prüfen

Structural Basis for Penetration of the Glycan Shield of Hepatitis C Virus E2 Glycoprotein by a Broadly Neutralizing Human Antibody

The Journal of biological chemistry, 2015-04, Vol.290 (16), p.10117-10125

2015

Link zum Volltext

Verfügbarkeit prüfen

Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells

Journal of virology, 2019-04, Vol.93 (7)

2019

Link zum Volltext

Verfügbarkeit prüfen

Affinity maturation of a broadly neutralizing human monoclonal antibody that prevents acute hepatitis C virus infection in mice

Hepatology (Baltimore, Md.), 2016-12, Vol.64 (6), p.1922-1933

2016

Link zum Volltext

Verfügbarkeit prüfen

Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design

PLoS pathogens, 2019-05, Vol.15 (5), p.e1007772-e1007772

2019

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes

Journal of Virology, 2010-06, Vol.84 (11), p.5751-5763

2010

Link zum Volltext

Verfügbarkeit prüfen

Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape

PLoS pathogens, 2013-05, Vol.9 (5), p.e1003364-e1003364

2013

Link zum Volltext

Verfügbarkeit prüfen

Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein

Journal of virology, 2016-01, Vol.90 (1), p.279-291

2016

Link zum Volltext

Verfügbarkeit prüfen

Mapping a Region of Hepatitis C Virus E2 That Is Responsible for Escape from Neutralizing Antibodies and a Core CD81-Binding Region That Does Not Tolerate Neutralization Escape Mutations

Journal of Virology, 2011-10, Vol.85 (20), p.10451-10463

2011

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design

Frontiers in immunology, 2018-06, Vol.9, p.1436-1436

2018

Link zum Volltext

Verfügbarkeit prüfen

Toward a Hepatitis C Virus Vaccine: the Structural Basis of Hepatitis C Virus Neutralization by AP33, a Broadly Neutralizing Antibody

Journal of Virology, 2012-12, Vol.86 (23), p.12923-12932

2012

Link zum Volltext

Verfügbarkeit prüfen

Designing a B Cell-Based Vaccine against a Highly Variable Hepatitis C Virus

Frontiers in microbiology, 2018-01, Vol.8, p.2692-2692

2018

Link zum Volltext

Verfügbarkeit prüfen

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

Journal of Virology, 2007-08, Vol.81 (15), p.8101-8111

2007

Link zum Volltext

Verfügbarkeit prüfen

Non-random escape pathways from a broadly neutralizing human monoclonal antibody map to a highly conserved region on the hepatitis C virus E2 glycoprotein encompassing amino acids 412-423

PLoS pathogens, 2014-08, Vol.10 (8), p.e1004297

2014

Link zum Volltext

Verfügbarkeit prüfen

Mutations That Alter Use of Hepatitis C Virus Cell Entry Factors Mediate Escape From Neutralizing Antibodies

Gastroenterology (New York, N.Y. 1943), 2012-07, Vol.143 (1), p.223-233.e9

2012

Link zum Volltext

Verfügbarkeit prüfen

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo

Antiviral research, 2017-12, Vol.148, p.53-64

2017

Link zum Volltext

Verfügbarkeit prüfen

Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein

Journal of general virology, 2008-03, Vol.89 (3), p.653-659

2008

Link zum Volltext

Verfügbarkeit prüfen

Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity

Journal of Virology, 2009-06, Vol.83 (12), p.6149-6160

2009

Link zum Volltext

Verfügbarkeit prüfen

Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies

Journal of Virology, 2008-06, Vol.82 (12), p.6061-6066

2008

Link zum Volltext

Verfügbarkeit prüfen

Neutralizing antibody response to hepatitis C virus

Viruses, 2011-11, Vol.3 (11), p.2127-2145

2011

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C Virus E2 Has Three Immunogenic Domains Containing Conformational Epitopes with Distinct Properties and Biological Functions

Journal of Virology, 2004-09, Vol.78 (17), p.9224-9232

2004

Link zum Volltext

Verfügbarkeit prüfen

In vitro selection of a neutralization-resistant hepatitis C virus escape mutant

Proceedings of the National Academy of Sciences - PNAS, 2008-12, Vol.105 (49), p.19450-19455

2008

Link zum Volltext

Verfügbarkeit prüfen

Immunogenic and Functional Organization of Hepatitis C Virus (HCV) Glycoprotein E2 on Infectious HCV Virions

Journal of Virology, 2007-01, Vol.81 (2), p.1043-1047

2007

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Interferon‐Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection

Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a

Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate

Structural Basis for Penetration of the Glycan Shield of Hepatitis C Virus E2 Glycoprotein by a Broadly Neutralizing Human Antibody

Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells

Affinity maturation of a broadly neutralizing human monoclonal antibody that prevents acute hepatitis C virus infection in mice

Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design

Hepatitis C Virus Hypervariable Region 1 Modulates Receptor Interactions, Conceals the CD81 Binding Site, and Protects Conserved Neutralizing Epitopes

Structural basis of HCV neutralization by human monoclonal antibodies resistant to viral neutralization escape

Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein

Mapping a Region of Hepatitis C Virus E2 That Is Responsible for Escape from Neutralizing Antibodies and a Core CD81-Binding Region That Does Not Tolerate Neutralization Escape Mutations

Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design

Toward a Hepatitis C Virus Vaccine: the Structural Basis of Hepatitis C Virus Neutralization by AP33, a Broadly Neutralizing Antibody

Designing a B Cell-Based Vaccine against a Highly Variable Hepatitis C Virus

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

Non-random escape pathways from a broadly neutralizing human monoclonal antibody map to a highly conserved region on the hepatitis C virus E2 glycoprotein encompassing amino acids 412-423

Mutations That Alter Use of Hepatitis C Virus Cell Entry Factors Mediate Escape From Neutralizing Antibodies

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo

Broadly neutralizing human monoclonal antibodies to the hepatitis C virus E2 glycoprotein

Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity

Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies

Neutralizing antibody response to hepatitis C virus

Hepatitis C Virus E2 Has Three Immunogenic Domains Containing Conformational Epitopes with Distinct Properties and Biological Functions

In vitro selection of a neutralization-resistant hepatitis C virus escape mutant

Immunogenic and Functional Organization of Hepatitis C Virus (HCV) Glycoprotein E2 on Infectious HCV Virions

Suchergebnisse filtern